| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/20/1996 | US5493019 Useful as antiinflammatory and antiproliferative agents |
| 02/20/1996 | US5493008 Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain |
| 02/20/1996 | US5492921 Preventing restenosis |
| 02/20/1996 | US5492897 Method for treating T-cell lymphoblastic leukemia with ara-G nucleoside derivatives |
| 02/20/1996 | CA2065271C New bis-platinum complexes as chemotherapeutic agents |
| 02/20/1996 | CA1338072C Conjugates for bone imaging and bone cancer therapy |
| 02/17/1996 | CA2156132A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 02/15/1996 | WO1996004313A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 02/15/1996 | WO1996004308A1 Cyclic hexapeptide somatostatin analogues |
| 02/15/1996 | WO1996004295A1 5'-dithio-modified oligonucleotides |
| 02/15/1996 | WO1996004292A1 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them |
| 02/15/1996 | WO1996004281A1 Substituted o6-benzylguanines and 6(4)-benzyloxypyrimidines |
| 02/15/1996 | WO1996004230A1 Terpene-quinone with antitumor activity |
| 02/15/1996 | WO1996004019A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 02/15/1996 | WO1996004008A1 Treatment of cancer with human chorionic gonadotropin |
| 02/15/1996 | WO1996003997A2 Treatment of cancer using hsv mutant |
| 02/15/1996 | WO1996003987A1 Lactone compounds for treating patients with precancerous lesions |
| 02/15/1996 | WO1996003983A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | WO1996000726A3 New brefeldin a derivatives and their utility in the treatment of cancer |
| 02/15/1996 | WO1995031991A3 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 02/15/1996 | DE4429398A1 Pharmazeutische Zusammensetzungen mit Estra-1,3,5(10)-trien-Derivaten Pharmaceutical compositions with Estra-1,3,5 (10) -triene derivatives |
| 02/15/1996 | CA2632452A1 Substituted o6-benzylguanines and use thereof |
| 02/15/1996 | CA2196776A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 02/15/1996 | CA2196752A1 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them |
| 02/15/1996 | CA2196748A1 Treatment of cancer with human chorionic gonadotropin |
| 02/15/1996 | CA2196701A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 02/15/1996 | CA2195864A1 5'-dithio-modified oligonucleotides |
| 02/15/1996 | CA2173157A1 Terpene-quinone with antitumor activity |
| 02/15/1996 | CA2172710A1 Lactone compounds for treating patients with precancerous lesions |
| 02/14/1996 | EP0696593A2 Inhibitors of farnesyl protein transferase |
| 02/14/1996 | EP0696456A2 Combination of necrosis inducing substances with substances which are activated by necrosis for the selective treatment of tumours and or inflammatory diseases |
| 02/14/1996 | EP0696455A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 02/14/1996 | EP0696326A1 Methods of treating and detecting cancer using viruses |
| 02/14/1996 | EP0696321A1 Macrophage inflammatory protein variants |
| 02/14/1996 | EP0696285A1 Water soluble derivatives of camptothecin and their use as antitumor agents |
| 02/14/1996 | EP0696275A1 Vitamin d amide derivatives |
| 02/14/1996 | EP0696270A1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs |
| 02/14/1996 | EP0696203A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis |
| 02/14/1996 | CN1116628A Cyclopeptides of the formulal |
| 02/14/1996 | CA2155920A1 Use of interferon for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells |
| 02/13/1996 | US5491237 Catalytic dehydroxylation, oxidation, enzymatic acylation, catalytic isomerization, cyclization, intramolecular heck reaction |
| 02/13/1996 | US5491231 Hindered N-oxide esters of rapamycin |
| 02/13/1996 | US5491229 Rapamycin derivative |
| 02/13/1996 | US5491164 Inhibitors of farnesyl-protein transferase |
| 02/13/1996 | US5491151 Administering to mammal, a cyanine dye for activation of macrophases in mammal |
| 02/13/1996 | US5491138 Estradiol derivative alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting composition containing the conjugate or estradiol derivative |
| 02/13/1996 | US5491088 Genetic engineering |
| 02/12/1996 | CA2155448A1 Inhibitors of farnesyl protein transferase |
| 02/08/1996 | WO1996003515A2 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | WO1996003501A1 Dual hybrid system |
| 02/08/1996 | WO1996003499A1 Receptor-ligand assay |
| 02/08/1996 | WO1996003437A1 PTH OR PTHrP ANTAGONISTS |
| 02/08/1996 | WO1996003430A1 Organic compounds |
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003414A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 02/08/1996 | WO1996003411A1 D-mannose or xylitol esters and their use as drugs |
| 02/08/1996 | WO1996003407A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 02/08/1996 | WO1996003406A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 02/08/1996 | WO1996003398A1 Hemoregulatory compounds |
| 02/08/1996 | WO1996003394A1 Semi-synthetic taxanes with anti-tumoural activity |
| 02/08/1996 | WO1996003393A1 Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same |
| 02/08/1996 | WO1996003151A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | WO1996003140A1 HLA binding peptides and their uses |
| 02/08/1996 | WO1996003130A1 Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 02/08/1996 | CA2196091A1 D-mannose or xylitol esters and their use as drugs |
| 02/08/1996 | CA2196052A1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | CA2196051A1 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | CA2195800A1 Receptor-ligand assay |
| 02/08/1996 | CA2195671A1 Hla binding peptides and their uses |
| 02/08/1996 | CA2195420A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 02/08/1996 | CA2192787A1 Pth or pthrp antagonists |
| 02/08/1996 | CA2187445A1 Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same |
| 02/07/1996 | EP0695759A2 Human cancer inhibitory pentapeptide methyl esters |
| 02/07/1996 | EP0695758A2 Human cancer inhibitory pentapeptide amides and esters |
| 02/07/1996 | EP0695757A2 Human cancer inhibitory peptide amides |
| 02/07/1996 | EP0695755A1 Pyrrolocarbazoles |
| 02/07/1996 | EP0695752A1 New anthraquinonic derivatives having an antitumor activity, and applications thereof |
| 02/07/1996 | EP0695360A1 Defective recombinant adenoviruses for gene therapy of tumours |
| 02/07/1996 | EP0695354A1 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-$g(b) (TGF-$g(b)) |
| 02/07/1996 | EP0695308A1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same |
| 02/07/1996 | EP0695305A1 Method of forming oligonucleotides |
| 02/07/1996 | EP0695293A1 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents |
| 02/07/1996 | EP0695187A1 Compositions for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid |
| 02/07/1996 | EP0695180A1 Novel medical use for gaba agonists |
| 02/07/1996 | EP0502049B1 Tumour necrosis factor antagonist |
| 02/07/1996 | EP0491053B1 Water-soluble bis-dioxopiperazine derivatives with antitumoral properties |
| 02/07/1996 | CN1116406A Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
| 02/07/1996 | CN1116206A Platinum complex and malignant tumor treating drug containing the same |
| 02/06/1996 | US5489698 4-Desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof |
| 02/06/1996 | US5489604 Treating degenerative diseases |
| 02/06/1996 | US5489589 Amino acid derivatives of paclitaxel |
| 02/06/1996 | US5489516 Hybridoma and monoclonal antibody specific for human stem cell factor receptor and methods of use of the monoclonal antibody for detection of stem cell factor receptors |
| 02/06/1996 | US5489508 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 02/05/1996 | CA2155397A1 Novel mutant br96 antibodies and functional equivalents reactive with human carcinomas |
| 02/05/1996 | CA2155148A1 Pyrrolocarbazoles |
| 02/02/1996 | CA2154206A1 Human cancer inhibitory pentapeptide amides and esters |
| 02/02/1996 | CA2154205A1 Human cancer inhibitory peptide amides |
| 02/02/1996 | CA2154203A1 Pentapeptide methyl esters |
| 02/01/1996 | WO1996002655A1 Nucleic acid containing composition, preparation and uses of same |
| 02/01/1996 | WO1996002642A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |